<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials
Image Overlay - Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

May 25, 2020

Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

Astrazeneca’s vaccine candidate has advanced to clinical trials with the prospect that it will be available by September. Yourway supports clinical trials to get them advanced to the clinic.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

GCSG 2026 European Knowledge Forum

October 14-15, 2026
Rome, Italy

Global Clinical Trial Supply Forum Europe

October 21-22, 2026
Frankfurt, Germany

Media

Articles

When “Urgent” Isn’t Just a Word

Open chat
Come chat with us!
Hello! How can I help you?